Uncategorized

February 28 is Rare Disease Day March 18, 2025 💡 Rare diseases disproportionately affect children, with a staggering two-thirds of American rare disease patients being kids. This sobering statistic underscores the critical importance of early detection and intervention – a mission that drives us at Clinakos Inc. Meet Anthony, whose story, shared by National Organization […]

Rare Disease Month February January 30, 2025 As Rare Disease Month approaches this February, we turn our attention to the extraordinary stories of individuals navigating life with conditions that often defy quick diagnosis and straightforward treatment. Their journeys are a testament to resilience and the urgent need for innovation. Recently, I came across with the

Meet Us at SCOPE 2025 February 28, 2025 With over 4,500 attendees and 1,200 organizations from 30 countries coming together in clinical operations, innovation, and digital health, SCOPE 2025 promises to be a game-changer for the industry. The 2025 agenda has been expanded to provide deeper coverage of Patient-Centric Trial Design, Generative AI, Small Biopharma

43rd Annual J.P Morgan Annual Healthcare Conference January 14, 2025 The energy is incredible—packed meetings, buzzing lobbies, and excitement everywhere! Key themes taking center stage:✨ Rare diseases and gene therapy, especially in immunology, are generating huge buzz.💡 Optimism about the IPO window reopening is energizing conversations.🤝 Deal activity is anticipated to pick up momentum.🏛️ Policy

22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas – Copy January 14, 2025 How Patient Data and AI are Revolutionizing Rare Disease Drug Development and Commercialization ✨The power of patient data and AI is reshaping how pharmaceutical companies approach drug development & commercialization—enabling unprecedented precision and speed. Imagine targeting the right patient population

Join Clinakos Inc. and Rare Patient Voice on February 4, 2025 January 2, 2025 Join Clinakos Inc. and Rare Patient Voice on February 4, 2025, for an engaging webinar:“Accelerating Rare Disease Drug Development and Commercialization: Bridging Data Gaps with Integrated Patient Data™ & AI.” Did you know it often takes years for rare disease patients

Happy holidays from Clinakos December 24, 2024 As the holiday season fills the air with warmth and joy, we take a moment to reflect on the partnerships, connections, and shared successes that have defined this past year. At Clinakos Inc., we are driven by a mission to foster innovation and collaboration across the lifesciences industry.

Wilson’s Disease Awareness Day December 6, 2024 As  December 6 approaches, we recognize Wilson’s Disease Awareness Day, a time to shed light on a rare condition that affects fewer than 1 in 30,000 people. Tarsha’s story, shared on the National Organization for Rare Disorders, is that the journey to a diagnosis was long and painful.

Day 3 at Piper Sandler Healthcare conference December 5, 2024 As we dive into Day 3 of the Piper Sandler Healthcare Conference today, our team at Clinakos Inc. was excited with the vibrant discussions and transformative ideas shaping the future of cell therapy for oncology. One such discussion yesterday was an important discussion on “The

22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas November 13, 2024 The leaders in rare diseases and orphan drug development are gathering today at the 22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas to discuss strategies and innovations to promote rare diseases product development and commercialization. One of the topics covered